AbbVie and Gilead Sciences each used the holiday season to reward their pipelines with a new clinical-stage cancer drug. Zejing…

In a groundbreaking advancement poised to redefine the landscape of nonlinear optics, recent research led by S. Zhang has unveiled…

In the realm of bioengineering, the generation of biomaterials with precise control over their structure, morphology, and physicochemical properties marks…

In a groundbreaking advancement at the frontier of photonics and soft matter physics, researchers have unveiled a novel class of…

In recent years, the cGAS-STING signaling pathway has emerged as a focal point of interest within the field of immunology…

Johnson & Johnson and Genmab both used the festive period to junk therapies that haven’t lived up to their promise…

The quest to understand Parkinson’s disease (PD), a neurodegenerative disorder characterized by motor dysfunction and a range of non-motor symptoms,…

In a groundbreaking study conducted by a team of researchers in Finland, a pressing concern has been illuminated—the unmet healthcare…

The intricate world of cardiac epigenetics emerges as a pivotal frontier in understanding heart diseases that plague millions globally. Heart…

In a groundbreaking development that challenges prevailing paradigms of cancer immunotherapy resistance, researchers have unveiled a novel intrinsic mechanism by…